ACR/ARHP Conference Coverage
October 21 to 23, 2018
Stem-cell transplant in scleroderma improves quantitative lung measures for up to 5 years
October 21, 2018
Improvements in quantitative lung scores were also shown to correlate directly with improvements in pulmonary function. [Read more]
Patients with SLE, depression, and fibromyalgia are more symptomatic, have higher perceived disease activity
October 21, 2018
New information on the association of these factors can help clinicians individualize management approaches. [Read more]
Myeloablative HSCT corrects molecular signatures in systemic sclerosis
October 21, 2018
No significant changes in these signatures were observed among study participants who received conventional therapy with cyclophosphamide. [Read more]
Long-term outcomes of the SCOT trial: benefits of myeloablative stem cell transplant in scleroderma are durable
October 22, 2018
Eleven years post-randomization, overall survival was significantly higher for the HSCT group than it was for the cyclophosphamide group, and other outcomes point to long-term benefits as well. [Read more]
Discordance between physician-assessed and patient-reported SLE disease activity in patients with SLE and fibromyalgia
October 22, 2018
Findings suggest that an increased awareness of symptom severity in patients with both conditions may help improve disease management. [Read more]
A quality improvement initiative increases adherence to HCQ dosing guidelines
October 22, 2018
Despite concerns about the risk for flares with dose reductions, physician adherence to AAO-recommended dosages increased to a peak of 87%. [Read more]
Pregnancy well-tolerated in women with sarcoidosis, autoimmune interstitial lung disease
October 23, 2018
Researchers conclude that it is not necessary for women with these conditions to avoid or terminate desired pregnancies, as was previously thought. [Read more]
Systemic sclerosis: fibroproliferative gene expression subset most likely to benefit from HSCT
October 23, 2018
Study findings suggest that a diagnostic test for intrinsic gene expression stratification could help clinical decision-making in the future. [Read more]
CARRA’s STOP JIA study update: enrollment complete, most children on step-up therapy
October 23, 2018
Physician preference, patient/family preference, and cost/insurance coverage were factors in the choice of CARRA consensus treatment plan. [Read more]